Want to see BNTC full AI Analyst Report?

Benitec Biopharma (BNTC) Financial Statements

319 Followers

Benitec Biopharma Financial Overview

Benitec Biopharma's market cap is currently $315.34M. The company's EPS TTM is $-0.98; its P/E ratio is -8.67; and it has a dividend yield of 0.12%. Benitec Biopharma is scheduled to report earnings on September 14, 2026, and the estimated EPS forecast is $-0.27. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 26	Jun 25	Jun 24	Jun 23	Jun 22
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 75.00K	$ 73.00K
Gross Profit	$ -481.00K	$ -396.00K	$ -343.00K	$ 75.00K	$ 64.00K
Operating Income	$ -51.19M	$ -41.77M	$ -22.49M	$ -19.08M	$ -17.85M
EBITDA	$ -50.71M	$ -41.37M	$ -22.15M	$ -18.70M	$ -17.78M
Net Income	$ -45.55M	$ -37.92M	$ -21.75M	$ -19.56M	$ -18.21M
Balance Sheet
Cash & Short-Term Investments	$ 179.97M	$ 97.74M	$ 50.87M	$ 2.48M	$ 4.06M
Total Assets	$ 182.62M	$ 99.59M	$ 52.21M	$ 4.46M	$ 5.97M
Total Debt	$ 762.00K	$ 849.00K	$ 284.00K	$ 559.00K	$ 811.00K
Net Debt	$ -179.21M	$ -96.89M	$ -50.58M	$ -1.92M	$ -3.25M
Total Liabilities	$ 5.61M	$ 2.30M	$ 4.96M	$ 4.26M	$ 3.09M
Stockholders' Equity	$ 177.01M	$ 97.30M	$ 47.25M	$ 202.00K	$ 2.88M
Cash Flow
Free Cash Flow	$ -16.62M	$ -23.61M	$ -19.58M	$ -18.01M	$ -15.91M
Operating Cash Flow	$ -16.52M	$ -23.59M	$ -19.40M	$ -18.01M	$ -15.90M
Investing Cash Flow	$ -105.00K	$ -18.00K	$ -179.00K	$ -1.00K	$ -13.00K
Financing Cash Flow	$ 98.98M	$ 70.48M	$ 68.03M	$ 16.02M	$ 0.00

Benitec Biopharma Earnings and Revenue History

Income Statement >

Benitec Biopharma Debt to Assets

Balance Sheet >

Benitec Biopharma Cash Flow

Cash Flow >

Benitec Biopharma Forecast EPS vs Actual EPS

Earnings >